Onderneming Protagonist Therapeutics, Inc.
Aandelen
PTGX
US74366E1029
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
25,15 USD | +1,99% | -1,80% | +9,68% |
Vakgebied
Aantal werknemers: 112
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125,73% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01-12-08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18-04-22 |
Chief Tech/Sci/R&D Officer | - | 01-07-17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 24-05-18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 07-11-22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 17-01-19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 01-01-17 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 01-09-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08-06-17 |
Harold Selick
CHM | Chairman | 69 | 01-02-09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26-10-23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01-12-08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 12-08-20 |
William Waddill
BRD | Director/Board Member | 67 | 01-07-16 |
Bryan Giraudo
BRD | Director/Board Member | 48 | 16-05-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 58 274 998 | 56 835 300 ( 97,53 %) | 0 | 97,53 % |
Bedrijfsgegevens
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,68% | 1,47 mld. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers PTGX
- Onderneming Protagonist Therapeutics, Inc.